ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
9,120 announcements with these filters
Q2FY27 revenue ₹271cr (+8% YoY), EBITDA ₹43cr (15.0% margin), PAT ₹16cr (-31% YoY) on RFP upfront investments; debt-free, ₹750cr cash.
Headline growth is strong: revenue up 30.5% to ₹940 Cr and EBITDA margin 22.8%, above the 21–22% guide. Sequentially, margin, gross margin and PAT all fell, and growth is partly acquired.
H1FY27 revenue Rs 512 Cr (+18%), adj. PAT Rs 50 Cr (+33%, 9.7% margin); reported PAT flat at Rs 36 Cr on ESOP charges. CDMO-led growth; Plant-6 commercialised.
Q2 FY27 revenue ₹157.4 Cr (+12% YoY), PAT ₹22.7 Cr; H1 revenue ₹475 Cr (+96%), H1 bookings ₹1,338 Cr (+120%).
Q2 FY27 total income ₹23.87 Cr (+20% YoY), EBITDA ₹6.00 Cr (25% margin, +492 bps), PAT ₹3.41 Cr (+76%). H1 PAT ₹5.51 Cr (+71%). Fortune 100 OEM supply programme won, ₹20 Cr+ annual potential.
Q2 FY27 Ind AS insurance revenue ₹2,720 cr (+1.7%); PAT ex-MTM ₹208 cr (-24.9%) on claims ratio 62.4%; CISR 99.8%; solvency 2.40x.
Q2 FY27 revenue Rs 3,076 Cr (+2.3% YoY), EBITDA Rs 36 Cr (1.2% margin), PAT Rs 26 Cr (-7% YoY). H1 revenue +4.0%, H1 PAT +14%. Management says Q2 was below aspirations.
Q2 FY27 revenue ₹87.35 Cr (+7.9% YoY), PAT ₹6.78 Cr (+113%), EBITDA margin 11.36%. Pivot to domestic B2B and NIBHANA LGD retail. No explicit guidance.
Revenue rose 27.9% to ₹85.4 Cr, but EBITDA and PAT margins both contracted, and capex of ₹19.9 Cr far exceeds ₹7.2 Cr operating cash flow.
Standalone PAT fell 33% YoY to ₹87 Cr and EBITDA fell 27% despite 21% higher income. Management blamed Middle East-driven energy and logistics costs and ATBS customer destocking.
Q2 FY27 consolidated revenue ₹10,225Mn (+26.8%), PAT ₹922Mn (+64.1%), EBITDA margin 17.0%. Record order book ₹226,811Mn; HAM monetisation and entry into transmission.
H1 FY27: AUM ₹326.4bn (+20% adj. YoY), PAT ₹5.9bn (+22% adj.; reported +17%), GNPA 1.3%, ROA 4.2%. Spreads stable at 5.7%.
Q2 FY27 revenue ~INR 1,576 Cr (+10%+), EBITDA INR 207 Cr; H1 revenue ~INR 3,100 Cr (+4%). Cash-focused: working capital cycle cut to 179 days; drought and polymer costs weigh on H2.
Q2 FY27 revenue ₹386 Cr (+18.8% YoY), adjusted EBITDA ₹71 Cr at 18.2%, PAT ₹36 Cr. Management steers investors away from PAT, avoids forward numbers, and leans on superlatives.
Record Q2 revenue of ₹538 Cr (+35%) and EBITDA of ₹151 Cr (28% margin), but gross margin fell roughly 700 bps and management deflected several key questions.
Standalone revenue grew 18.9% but PBDIT only 4.9%, as raw-material inflation of about 25% outran 7-8% price hikes. Management deflects to 'sequential improvement' rather than quantifying margin recovery.
Q2 FY27 standalone: total income Rs339.3cr (+8.8% YoY), EBITDA Rs43.0cr (12.7% margin), PAT Rs26.7cr (+6.0%). Strategy centres on multimodal expansion, automation and capex.
Q2FY27 revenue INR 581.5 mn (+51% QoQ), PAT INR 41.2 mn (+238% QoQ), EBITA INR 81.88 mn (+74% QoQ). Growth led by North America; defence shell programmes progressing.
Q2 FY27 revenue rose 30% to ₹661 Cr at a 12.8% EBITDA margin. H1 operating cash flow of ₹56 Cr is reported, and management highlights ₹125 Cr excluding a ₹68 Cr payables payment. Order book is ₹3,093 Cr, but H1 volumes fell about 13%.
Q2 revenue rose 16.9% to ₹452 Cr, but EBITDA margin fell to 13.5% and gross margin dropped to 51.4%. The FY27 17% EBITDA margin target needs a sharp H2 recovery.
Q2/H1 FY27 deck; no quarterly revenue, PAT or EBITDA disclosed. Highlights FY23–FY26 margin gains and H1 FY27 field-activity metrics.
Q2 FY27: revenue from operations ₹9,385 Mn (+13.0% YoY), EBITDA ₹1,187 Mn (-7.4%), PAT ₹690 Mn (-11.2%), EBITDA margin 12.6%. Ethnic snacks +19.7%.
Q2 FY27 revenue ₹902.6 Cr (+77% QoQ, +17.5% YoY), PAT ₹20.2 Cr, EBITDA margin 7.7%. Odisha integrated cell-module expansion is ramping.
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Record Q2 revenue of ₹318 Cr (+17% YoY) and H1 EBITA margin up to 7.8%, but the Mahad plant drag, weak camphor volumes and undisclosed Unilever terms temper the story.
H1 FY27 Group total income Rs 60,356 Mn, adj EBITDA Rs 8,720 Mn (14%), adj PAT Rs 452 Mn after Molycop grinding media loss. Tega ex-Molycop adj PAT Rs 602 Mn.
Q2 revenue ₹6,655 Cr (+38%), EBITDA ₹733 Cr at 11% margin, PAT ₹420 Cr (+38%). Casting growth partly reflects metal price pass-through, and net debt rose to ₹2,415 Cr.
Q2 FY27 operating revenue rose 13% YoY; EBITDA INR708m (3.2% margin) and PAT INR456m. FIFA-driven digital surge, but margins were hit by sports and new-initiative spends.
Q2 FY27 revenue Rs3,757mn (record, +127% YoY), EBITDA Rs1,188mn (31.6%), PAT Rs1,025mn (27.3%). H1 FY27 revenue Rs6,689mn, PAT Rs1,808mn. Growth led by pharma intermediates and API.
H1FY27 revenue ₹980 Cr (+52%), EBITDA ₹98 Cr (10% margin), PAT ₹69 Cr (+56%). Q2 revenue +50% but EBITDA margin compressed to 6.6%.